Abbott Laboratories (ABT)
NYSE · Healthcare
Abbott Laboratories Long Term Debt 2007–2025
Abbott Laboratories annual long term debt history from 2007 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Abbott Laboratories long term debt as of December 31, 2025: 12.93B, a 8.47% decrease year-over-year.
- Abbott Laboratories long term debt for 2025 were 12.93B, a 8.47% decrease from 2024.
- Abbott Laboratories long term debt for 2024 were 14.13B, a 3.77% decrease from 2023.
- Abbott Laboratories long term debt for 2023 were 14.68B, a 12.48% decrease from 2022.
- Abbott Laboratories long term debt for 2022 were 16.77B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Abbott Laboratories Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $12,929 |
| 2024 | $14,125 |
| 2023 | $14,679 |
| 2022 | $16,773 |
| 2021 | $18,050 |
| 2020 | $18,534 |
| 2019 | $17,938 |
| 2018 | $19,366 |
| 2017 | $27,718 |
| 2016 | $20,684 |
| 2015 | $5,874 |
| 2014 | $3,448 |
| 2013 | $3,397 |
| 2012 | $18,394 |
| 2011 | $13,067 |
Abbott Laboratories Long Term Debt — FAQ
Abbott Laboratories (ABT) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABT's long term debt history?
The chart and table above show Abbott Laboratories's long term debt by year and by quarter, including the growth rate.